Role of Tspan5 in MHC I antigen presentation and cancer immune evasion
Tspan5 在 MHC I 抗原呈递和癌症免疫逃避中的作用
基本信息
- 批准号:10584551
- 负责人:
- 金额:$ 49.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAffectAntigen PresentationAntigen-Presenting CellsAtomic Force MicroscopyBindingBiologicalBiological MarkersCD8-Positive T-LymphocytesCancer ControlCancer PatientCell membraneCellsCessation of lifeClinicalClinical ResearchComplexCross PresentationDataDendritic CellsDiseaseElectron MicroscopyEndoplasmic ReticulumExclusionFamily memberFormalinGenetic ScreeningGoalsHemagglutininHost DefenseHumanI-antigenImmuneImmune EvasionImmune responseImmune systemImmunohistochemistryImmunologic SurveillanceImmunoprecipitationImmunotherapyKineticsLigandsMHC Class II GenesMajor Histocompatibility ComplexMalignant NeoplasmsMass Spectrum AnalysisMembraneMembrane MicrodomainsModelingMolecularMusOutcomeParaffin EmbeddingPathologicPatientsPeptide/MHC ComplexPeptidesPhysiologyPre-Clinical ModelProcessRegulationRenal Cell CarcinomaResistanceRoleScanningSignal TransductionT cell responseT-Cell ReceptorT-LymphocyteTestingTimeTranscriptTranslatingTumor EscapeViralVirusWestern BlottingWild Type Mousecancer immunotherapyclinical predictorsclinical translationcohortdensityexperimental studyfightinggain of functionimmune checkpoint blockadeimmune clearanceimmunogenicimprovedinhibitorinsightloss of functionnovelpreclinical studypreventprogrammed cell death ligand 1programmed cell death protein 1receptorresponsetherapeutic targettreatment and outcometumor
项目摘要
Abstract
CD8 T lymphocytes are the major mechanism by which the immune system eliminates cancers and virally
infected cells. CD8 T cells detect these abnormal targets by recognizing immunogenic peptides displayed on
MHC I molecules. Cancers and viruses can evade immune control by inhibiting MHC I antigen presentation,
making it harder for CD8 T lymphocytes to detect and kill these pathological cells. Therefore, it is important to
understand the mechanisms that regulate antigen presentation as well as the mechanisms by which tumors
dysregulate these processes - this is the overall goal of this proposal. Our proposal is based on our discovery in
an unbiased forward genetic screen of a Tetraspanin (Tspan5) that unexpectedly organizes MHC I molecules in
ways that amplify theair ability to stimulate CD8 T cell responses. Our 1st aim will elucidate the underlying
molecular mechanisms for this biological effect. This Aim will test the hypothesis that Tspan5 organizes MHC I
molecules into stimulatory membrane microdomains that by virtue of size, MHC I density and/or incorporation of
other key ligands markedly increases the efficiency of antigen presentation. Our 2nd aim will elucidate how, when
and where Tspan5-MHC I microdomains form. This aim will test the hypotheses that peptide-MHC I complexes
are incorporated into Tspan5 immunostimulatory microdomains upon release from the peptide-loading complex
in the ER, through specific molecular interactions with Tspan5 and other Tspan family members, and then these
immunostimulatory microdomains are trafficked to and maintained on the plasma membrane for display. Our 3rd
Aim is based on our finding that certain cancers, including renal cell carcinomas, significantly downregulate
Tspan 5 expression. The hypothesis underlying our 3rd Aim is that this loss of expression of Tspan5 is one of the
ways that cancers escape immune surveillance and control and thereby progress. A corollary of this hypothesis
is that the loss of Tspan5 is a mechanism that will influence resistance to immunotherapy; as such, Tspan5 could
provide a much-needed biomarker for identifying patients who will not respond to immunotherapy and could also
be a potential therapeutic target to restore responses to such therapy. Our experimental approach will use
isogenic Tspan5-edited renal cell cancers (loss of function and gain of function) in preclinical models with
humanized and wild type mice to define the role of Tspan5 in tumor immune evasion and responsiveness to
immunotherapy with checkpoint blockade for both human and mouse tumors. Finally, we will translate these
findings into human cancer patients by investigating whether Tspan5 expression is a biomarker that can predict
clinical course. Our hypotheses and feasibility of the proposed experiments are supported by strong preliminary
data. Taken together, our proposed experiments will go from basic mechanistic studies, which will elucidate a
potentially fundamental and novel mechanism for optimizing the ability of APCs to stimulate T cell responses, to
preclinical and clinical studies, which will define how loss of this mechanism affects immune control of cancers
and clinical outcomes.
摘要
CD 8 T淋巴细胞是免疫系统消除癌症和病毒的主要机制。
被感染的细胞CD 8 T细胞通过识别细胞表面上展示的免疫原性肽来检测这些异常靶标。
MHC I分子。癌症和病毒可以通过抑制MHC I抗原呈递来逃避免疫控制,
这使得CD 8 T淋巴细胞更难检测和杀死这些病理细胞。因此,
了解调节抗原呈递的机制以及肿瘤
使这些过程失去控制-这是本提案的总体目标。我们的建议是基于我们在
一种四跨膜蛋白(Tspan 5)的无偏正向遗传筛选,它意外地组织了MHC I分子,
增强空气刺激CD 8 T细胞反应的能力。我们的第一个目标将阐明
这种生物效应的分子机制。本研究旨在验证Tspan 5组织MHC I的假设
分子进入刺激性膜微区,所述微区凭借大小、MHC I密度和/或MHC I分子的掺入,
其它关键配体显著增加抗原呈递的效率。我们的第二个目标将阐明如何,当
以及Tspan 5-MHCI微区形成的位置。这一目的将检验肽-MHC I复合物
在从肽负载复合物释放时掺入Tspan 5免疫刺激微结构域
在ER中,通过与Tspan 5和其他Tspan家族成员的特异性分子相互作用,然后这些
免疫刺激微结构域被运输到质膜并保持在质膜上用于展示。我们的第三个
目的是基于我们的发现,某些癌症,包括肾细胞癌,
Tspan 5表达。我们的第三个目标的假设是Tspan 5表达的缺失是导致细胞凋亡的原因之一。
癌症逃避免疫监视和控制从而发展的方式。这个假设的推论
Tspan 5的缺失是一种影响免疫治疗抗性的机制;因此,Tspan 5可能
提供了一种急需的生物标志物,用于识别对免疫治疗无反应的患者,
是恢复对这种治疗的反应的潜在治疗靶点。我们的实验方法将使用
临床前模型中的同基因Tspan 5编辑的肾细胞癌(功能丧失和功能获得),
人源化和野生型小鼠,以确定Tspan 5在肿瘤免疫逃避和对肿瘤免疫应答中的作用。
免疫治疗与检查点阻断用于人类和小鼠肿瘤。最后,我们将这些
通过研究Tspan 5表达是否是一种可以预测癌症的生物标志物,
临床过程我们的假设和建议的实验的可行性是支持强初步
数据总之,我们提出的实验将从基本的机理研究,这将阐明一个
优化APC刺激T细胞应答的能力的潜在基础和新机制,
临床前和临床研究,将确定这种机制的丧失如何影响癌症的免疫控制
临床结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH L ROCK其他文献
KENNETH L ROCK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH L ROCK', 18)}}的其他基金
Novel histone-binding C-type lectin receptors and their role in sterile inflammation and tissue injury
新型组蛋白结合 C 型凝集素受体及其在无菌炎症和组织损伤中的作用
- 批准号:
10566947 - 财政年份:2022
- 资助金额:
$ 49.58万 - 项目类别:
Role of IRF2 in cancer immune evasion and immunotherapy
IRF2在癌症免疫逃避和免疫治疗中的作用
- 批准号:
10204986 - 财政年份:2020
- 资助金额:
$ 49.58万 - 项目类别:
Role of IRF2 in cancer immune evasion and immunotherapy
IRF2在癌症免疫逃避和免疫治疗中的作用
- 批准号:
10414938 - 财政年份:2020
- 资助金额:
$ 49.58万 - 项目类别:
Role of IRF2 in cancer immune evasion and immunotherapy
IRF2在癌症免疫逃避和免疫治疗中的作用
- 批准号:
10667446 - 财政年份:2020
- 资助金额:
$ 49.58万 - 项目类别:
Mechanisms of cross-presenting antigens in phagosomes on MHC I molecules to stimulate CD8 T lymphocyte responses
MHC I分子上的吞噬体中交叉呈递抗原刺激CD8 T淋巴细胞反应的机制
- 批准号:
9797712 - 财政年份:2019
- 资助金额:
$ 49.58万 - 项目类别:
Mechanisms of cross-presenting antigens in phagosomes on MHC I molecules to stimulate CD8 T lymphocyte responses
MHC I分子上的吞噬体中交叉呈递抗原刺激CD8 T淋巴细胞反应的机制
- 批准号:
10392945 - 财政年份:2019
- 资助金额:
$ 49.58万 - 项目类别:
Mechanisms of cross-presenting antigens in phagosomes on MHC I molecules to stimulate CD8 T lymphocyte responses
MHC I分子上的吞噬体中交叉呈递抗原刺激CD8 T淋巴细胞反应的机制
- 批准号:
10606598 - 财政年份:2019
- 资助金额:
$ 49.58万 - 项目类别:
Role of Clec2d-DAMP interactions in the pathophysiology of tissue injury and sepsis
Clec2d-DAMP 相互作用在组织损伤和脓毒症病理生理学中的作用
- 批准号:
10164709 - 财政年份:2017
- 资助金额:
$ 49.58万 - 项目类别:
Role of Tspan5 in MHC I antigen presentation and cancer immune evasion
Tspan5 在 MHC I 抗原呈递和癌症免疫逃避中的作用
- 批准号:
10210168 - 财政年份:2016
- 资助金额:
$ 49.58万 - 项目类别:
Role of Tspan5 in MHC I antigen presentation and cancer immune evasion
Tspan5 在 MHC I 抗原呈递和癌症免疫逃避中的作用
- 批准号:
10362713 - 财政年份:2016
- 资助金额:
$ 49.58万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 49.58万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 49.58万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 49.58万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 49.58万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 49.58万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 49.58万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 49.58万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 49.58万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 49.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 49.58万 - 项目类别:
Studentship